€1.2m · Other round · AI · Hamburg, Germany
Hamburg-based Qodia has raised €1.2m in a funding round to expand its AI software for private medical billing in Germany. Startup City Hamburg first reported the round on 12 August 2026, saying the backer is a leading financial-services provider in healthcare that chose to remain unnamed. Qodia later confirmed the financing and said it will invest in product and GOÄ expertise, partner relationships and the quality of its AI systems.
The round follows about €400k raised in 2025, bringing Qodia's publicly communicated funding to roughly €1.6m. The company was founded in 2024 by Ole Reinpold, Lasse Reinpold, Nicolas Riegger and Stephan Lenert.
Turning billing rules into operational software
Qodia focuses on the German private-medical fee schedule, or GOÄ. Its software checks billing files for missing or incompatible codes and suggests optimisations; a separate assistant answers GOÄ questions against a structured ruleset. An early-access product is intended to translate treatment documentation into billable codes and a proposed invoice, with staff retaining control over the result.
The commercial mechanism is narrower than a general healthcare AI platform. Billing centres and service providers process large numbers of invoices under the same underlying fee schedule, but every additional case can create more manual review. Qodia's approach is to encode that domain knowledge once, then apply it across recurring workflows while allowing organisation- and doctor-specific rules. If the system proves reliable, customers can increase throughput without adding review work at the same rate as invoice volume.
Qodia told Startup City Hamburg that its two live products were used by 11 large customers, eight of which joined in May and June 2026, and that its team had grown to 14 people. Those are company-supplied figures rather than independently audited metrics, but they give the round a concrete execution test: convert early billing-centre adoption into repeatable deployments while preserving the accuracy demanded by a regulated workflow.
From checking invoices to creating them
The third product is the larger step. Qodia said it was testing automated analysis of treatment records with pilot customers and planned a release by the end of 2026. That moves the product earlier in the revenue cycle, from checking an existing invoice to helping create one from clinical documentation. It may also deepen integration requirements and raise the cost of errors, which is why Qodia describes its output as proposals grounded in a structured GOÄ rule base rather than autonomous final billing.
An unnamed strategic investor limits visibility into the round's terms, but the investor profile matters commercially: a healthcare financial-services provider may understand how billing centres buy, integrate and validate this kind of software. The useful milestone after the funding will be whether Qodia can turn that industry access into durable distribution without outrunning product validation.
Sources checked:
Startup City Hamburg · Qodia funding announcement · Qodia product site · Qodia company page · Tech.eu Funding Explorer
